scispace - formally typeset
Search or ask a question

Is CANCA1a associted with diseases? 


Best insight from top research papers

CACNA1A is indeed associated with various diseases. Pathogenic variants in the CACNA1A gene have been linked to episodic ataxia type 2, familial hemiplegic migraine, spinocerebellar ataxia 6, developmental delay, epilepsy, paroxysmal dystonia, and neuropsychiatric disorders . Additionally, CACNA1A variants have been connected to a broad spectrum of phenotypes, ranging from episodic or progressive ataxia to more complex ataxia syndromes, intellectual disability, and epilepsy . Furthermore, CACNA1C variants have been associated with multiple neuropsychiatric disorders, with strong implications for schizophrenia and bipolar disorder, suggesting shared risk and pathophysiology among these conditions . Overall, these findings highlight the diverse disease manifestations linked to CACNA1A and CACNA1C, emphasizing the importance of understanding genotype-phenotype correlations for prognosis and potential therapeutic interventions.

Answers from top 5 papers

More filters
Papers (5)Insight
Yes, CACNA1A haploinsufficiency is associated with cognitive impairment, autism, epileptic encephalopathy, and mild cerebellar symptoms, as indicated in the research paper.
Yes, CACNA1C variants are associated with multiple neuropsychiatric disorders, including schizophrenia, bipolar disorder, and others, suggesting a pleiotropic role in these conditions.
Yes, CANCA1a, also known as CRIP1a, is associated with various diseases including schizophrenia, cancer subtypes, and regulation of sensory systems, suggesting a role in health and disease.
Yes, CACNA1A is associated with episodic ataxia type 2, familial hemiplegic migraine type 1, spinocerebellar ataxia type 6, and a broader spectrum of neurogenetic phenotypes.

Related Questions

CAn diet be a treatment for CACNA1A mutation?5 answersDiet can be a potential treatment for CACNA1A mutations. While CACNA1A mutations are linked to familial hemiplegic migraine type 1 and episodic ataxia type 2, a patient with these mutations experienced relief from attacks with acetazolamide treatment. Additionally, dietary interventions have shown efficacy in treating genetic and epigenetic diseases, including those involving mutations like SCN2A, through the use of ketogenic diets. Specifically, a patient with SCN2A mutation and early-onset epileptic encephalopathies benefited from a ketogenic diet, showcasing the potential of dietary approaches in managing genetic disorders associated with mutations like CACNA1A. Therefore, dietary strategies, such as ketogenic diets, could be considered as part of a comprehensive treatment plan for individuals with CACNA1A mutations.
O uso de cannabidiol para cães, auxilia nos tratamentos de doenças neurológicas?4 answersO uso de canabidiol em cães tem sido explorado para auxiliar no tratamento de doenças neurológicas. Estudos indicam que a Cannabis e seus derivados, como o canabidiol, possuem propriedades terapêuticas relevantes, atuando como analgésicos e anticonvulsivantes em animais, incluindo cães. A pesquisa destaca a importância de investigar o uso da Cannabis em cães com dores crônicas, ressaltando sua ação analgésica nessa espécie. Além disso, a revisão bibliográfica aponta que o sistema endocanabinóide, no qual o canabidiol atua, possui efeitos neuromoduladores que podem ser benéficos no controle da dor e na redução dos sintomas de doenças neurológicas em humanos. Portanto, o canabidiol pode ser uma opção terapêutica promissora para auxiliar no tratamento de doenças neurológicas em cães.
What diseases is s-palmitoylation associated with?5 answersS-Palmitoylation is associated with various diseases, including neurodegenerative diseases like Alzheimer's disease, Parkinson's disease, and Huntington's disease. Additionally, palmitoylation has been linked to apoptosis, a process crucial for maintaining organismal homeostasis and implicated in inflammatory and immune diseases. In the context of cardiac diseases, alterations in S-palmitoylation have been observed in left ventricular hypertrophy (LVH) and heart failure (HF), with changes in the expression of zDHHC5, a key enzyme involved in palmitoylation, being associated with these conditions. Furthermore, in Parkinson's disease, the palmitoylation of synaptotagmin-11 (Syt11) has been shown to impact α-synuclein homeostasis in neurons, potentially contributing to pathological α-synuclein aggregation.
What disease does Dorea have to do with?5 answersDorea is a term associated with various contexts. In Greek history, Dorea refers to a "gift". In microbiology, Dorea phocaeensis is a newly identified species isolated from a healthy individual's stool. Moving to medical contexts, osteoarthritis, a common degenerative joint disease, involves catabolic alterations in cartilage matrix, leading to pain and functional loss. Furthermore, advancements in understanding pain mechanisms in knee osteoarthritis suggest central nervous system involvement in maintaining and amplifying pain, highlighting the importance of targeting central nervous system structures for effective management. Lastly, Donohue syndrome, a rare autosomal recessive disorder, is characterized by severe insulin resistance and metabolic abnormalities such as hyperinsulinemia, hypoglycemia, and hypertrophic cardiomyopathy.
Who has a lot of disease anxiety?5 answersMedical students have less disease anxiety compared to law students, contrary to what is often believed. Adults with congenital heart disease (CHD) may experience heart-focused anxiety related to their medical condition. Patients with Parkinson's disease (PD) commonly experience anxiety, with up to 40% of patients fulfilling criteria for anxiety disorders. Women with heart disease are more vulnerable to anxiety and depression.
What are some of the most important disease associations?3 answersSome of the most important disease associations include the increased incidence of obstructive sleep apnoea (OSA), restless leg syndrome (RLS), and periodic limb movements in sleep (PLMS) in patients with Charcot-Marie-Tooth disease type 1 (CMT1). Disease association studies aim to uncover genetic risk factors for common diseases and facilitate disease prediction, early diagnosis, and enhanced prognosis. Major histocompatibility complex (MHC) alleles can be used as markers for autoimmune and other disorders, but the identification of true susceptibility genetic loci is challenging. There is a causal relationship between cardiovascular disease and cancer, with shared mechanisms such as inflammation, neuro-hormonal activation, oxidative stress, and a dysfunctional immune system. Understanding disease-disease associations can help healthcare providers diagnose, prevent, and treat co-occurring conditions more effectively.

See what other people are reading

Whats the impact of family issues as a contextual factor on outcomes for those with first episode psychosis?
5 answers
Family issues play a crucial role in the outcomes of individuals experiencing first-episode psychosis (FEP). Research indicates that high familial load for schizophrenia, environmental risk factors, and polygenic risk factors contribute to poor long-term functional outcomes in FEP patients. Additionally, family engagement has been shown to significantly impact patient disengagement from early intervention services, with higher family contact correlating with lower patient disengagement rates. Moreover, family environments characterized by emotional over-involvement and the presence of major depressive episodes within the family are predictors of psychotic relapses in FEP patients, emphasizing the importance of addressing family dynamics and depression in the care of individuals with FEP. Understanding and addressing family issues are essential for improving the prognosis and overall well-being of individuals with first-episode psychosis.
What are some of the key insights or arguments presented by Brandstetter?
5 answers
Brandstätter et al. presented insights regarding decision-making processes, particularly in risky choices. They compared various models, including the priority heuristic, expected value (EV) rule, and cumulative prospect theory (CPT), to explain how individuals make decisions between gambles. Brandstätter et al. argued that the EV rule combined with the priority heuristic did not fit as well as the CPT or the transfer of attention exchange (TAX) model in predicting choices. They highlighted the limitations of using an "as-if" model like the EV rule and emphasized the need to consider additional heuristics when explaining decision-making behavior. Brandstätter et al. also suggested that failures of the EV plus priority heuristic model should be seen as evidence for the existence of other decision-making heuristics.
How symptom burden related to quality of life for psychiatry?
4 answers
Symptom burden in psychiatric disorders is intricately linked to the quality of life (QoL) of patients and their caregivers. Studies have shown that patients with psychiatric disorders experience poorer QoL compared to healthy controls, emphasizing the impact of symptoms on overall well-being. Furthermore, caregivers of patients with psychiatric disorders, such as schizophrenia and chronic depression, experience a significant negative correlation between caregiver burden and QoL, indicating that as burden increases, QoL decreases. In the case of major neurocognitive disorder (mNCD), neuropsychiatric symptoms (NPSs) have been found to strongly correlate with QoL and caregiver burden, with NPSs having a twice stronger impact on caregiver burden than cognitive decline. Therefore, addressing symptom burden in psychiatric disorders is crucial for improving the QoL of both patients and their caregivers.
What is the definition of cognitive impairment in relation to academics?
4 answers
Cognitive impairment in relation to academics refers to deficits in cognitive abilities that impact a student's learning and educational performance. This impairment can manifest as difficulties in information processing speed, working memory, number sense, and fluid intelligence. Research suggests that cognitive abilities play a crucial role in academic achievement, with a positive association between academic success and cognitive ability. Cognitive dysfunction is a recognized feature of mood disorders like major depressive disorder and bipolar disorder, which can affect academic outcomes and functional performance. Furthermore, depression associated with cognitive impairment can lead to challenges in attention, concentration, and critical thinking, hindering academic progress and potentially causing a decline in academic performance. Understanding and addressing cognitive impairment are essential for optimizing educational outcomes and supporting students in their academic journey.
Why is emotional involvement bad in therapy?
4 answers
Emotional involvement in therapy can have negative implications due to various factors highlighted in the research contexts. For instance, inappropriate emotional responses from relatives, such as self-sacrifice and distress, can impact the effectiveness of family-based interventions for bipolar disorder patients. Additionally, emotional upheavals following extra-marital involvement can create challenging therapy contexts, affecting marital relationships. Moreover, the reluctance to address emotional aspects in medical practice can lead to therapeutic errors and hinder the acquisition of psychosocial knowledge. These instances underscore the importance of managing emotional involvement in therapy to ensure optimal treatment outcomes and avoid potential pitfalls associated with emotional dynamics in therapeutic settings.
How are IPSC studies used to determine the neurodevelopmental role of loci implicated in Schizophrenia, such as CACNA1D?
5 answers
IPSC studies play a crucial role in investigating the neurodevelopmental implications of loci associated with schizophrenia, such as CACNA1D. These studies utilize induced pluripotent stem cells to model the disease, allowing for the examination of neurodevelopmental processes affected by genetic vulnerabilities. By analyzing gene expression patterns and functional changes in astrocytes and neurons derived from IPSCs of schizophrenia patients, researchers have identified alterations in calcium signaling, glutamate uptake, and metalloproteinase activity, implicating these processes in the pathology of schizophrenia. Additionally, IPSC studies have revealed deficiencies in neural connectivity, neurite outgrowth, and the misexpression of genes like NRG1, ZNF804A, and TCF4, shedding light on the developmental abnormalities associated with schizophrenia.
What are the implications of using machine learning algorithms for predicting and diagnosing mental health disorders?
5 answers
Machine learning algorithms play a crucial role in predicting and diagnosing mental health disorders. They can accurately predict mental health outcomes by analyzing various datasets, including patient questionnaires and MRI scans. These algorithms can help in identifying individuals who require medical intervention for mental health issues, leading to timely and effective treatment. By utilizing techniques like stop word removal and lemmatization, the processed data can be encoded to enhance prediction accuracy. Additionally, machine learning models can detect psychological instability, such as bipolar disorder, by analyzing real-time datasets and survey questionnaires, ultimately aiding in reducing the severity and risks associated with such disorders. Overall, the use of machine learning in mental health evaluation shows promise in creating accessible and accurate tools for better detection and treatment of mental health disorders.
What is the role of genes coding dopamine receptors in depression?
7 answers
The role of genes coding for dopamine receptors in depression is multifaceted and complex, involving both direct and indirect pathways that influence depressive symptomatology. Research indicates that sequence variations in genes regulating dopamine neurotransmission, including those coding for dopamine receptors, may significantly influence depressive symptoms. For instance, a study found that a genetic risk score combining functional polymorphisms from dopamine receptor genes (DRD1, DRD2, DRD3) was associated with depressive symptomatology, suggesting that lower dopaminergic neurotransmission predicts higher levels of depression. This is further supported by findings that functional variants of the dopamine D4 receptor (DRD4) gene might be associated with depressive symptomatology, particularly delusional symptoms in mood disorders. Moreover, the role of dopamine receptors extends to their distribution in various brain regions and their involvement in neuroinflammatory processes that contribute to depression. The dopamine D3 receptor (D3R), for example, has been shown to influence depressive-like behaviors, neuroinflammation, and alterations in brain-derived neurotrophic factor (BDNF) levels in mesolimbic dopaminergic regions. Additionally, alterations in D3R expression and function have been correlated with depression severity, with evidence suggesting that D3R modulation can influence proinflammatory cytokines and the ERK1/2-cAMP-response element-binding protein (CREB) signaling pathway, which are critical in the pathophysiology of depression. The interaction between genetic predisposition and environmental factors also plays a crucial role in the etiology of depression. Studies highlight the importance of gene-gene-environment interactions, demonstrating that individuals with specific genotypes of COMT and DAT1 genes, which are involved in dopamine metabolism, are more sensitive to environmental factors like peer acceptance, which in turn affects depressive symptoms. In summary, genes coding for dopamine receptors play a critical role in depression through their influence on dopaminergic neurotransmission, interaction with environmental factors, and involvement in neuroinflammatory processes. These findings underscore the complexity of the genetic underpinnings of depression and highlight the potential for targeted therapeutic interventions.
What is the role of genes coding dopamine receptors in depression? conflicting results?
7 answers
The role of genes coding for dopamine receptors in depression has been a subject of extensive research, yielding both promising insights and conflicting results. Studies have identified significant associations between dopamine receptor genes and major depressive disorder (MDD), suggesting that these genes may influence susceptibility to depression and the efficacy of treatments. For instance, polymorphisms in the dopamine transporter gene (SLC6A3/DAT1) and dopamine receptor genes (DRD4, DRD2) have been linked to depressive symptoms and disorders, with specific alleles associated with mixed anxiety and depressive disorder. Moreover, variants in the DRD2 gene have been implicated in the comorbidity of type 2 diabetes (T2D) and MDD, highlighting a potential genetic overlap between these conditions. Further research supports the involvement of the DRD2 gene in MDD susceptibility and the response to selective serotonin reuptake inhibitors (SSRIs), a common class of antidepressants. Additionally, genetic interactions involving the DRD1 and DRD2 genes have been associated with the manifestation of depressive symptoms in children and adolescents, suggesting a complex interplay between multiple dopamine receptor genes. The DRD3 gene, in particular, has been linked to MDD and nicotine dependence (ND), with evidence suggesting that ND may amplify the genetic risk of MDD conferred by DRD3 variants. However, the relationship between dopamine-related genes and depression is not straightforward. While some studies have found associations between dopamine polymorphisms and depressive symptomatology, others have not found a significant interaction between DRD4 polymorphisms and childhood adversity in the development of depressive symptoms. This inconsistency is further illustrated by research showing a significant association between DRD3 variants and the efficacy of electroconvulsive therapy (ECT) in treatment-resistant MDD, suggesting that genetic variation in dopamine receptors can influence treatment outcomes. In summary, while there is evidence to support the role of dopamine receptor genes in depression, the findings are varied and sometimes conflicting. This heterogeneity may be attributed to the complex nature of depression, the diversity of the studied populations, and the multifaceted interactions between genetic and environmental factors.
Canine nutrition and DNA methylation
5 answers
Canine nutrition plays a crucial role in DNA methylation, impacting gene expression and health outcomes. Studies have shown that nutrients acquired through the diet, such as folate, choline, and betaine, are essential for DNA methylation within the one-carbon metabolism pathway. Nutritional epigenomics focuses on how nutrients influence gene expression through DNA methylation, highlighting the significance of methyl donors in diet-gene interactions. Additionally, research on dogs has demonstrated that DNA methylation profiles can predict behavioral traits, indicating a link between epigenetic modifications and behavior. Understanding the interplay between canine nutrition and DNA methylation is vital for comprehending the mechanisms underlying gene regulation and health outcomes in dogs.
Is there a basis for Homogentisate dioxygénase (HGO/HGD) inhibition by fluoroquinolones ?
5 answers
Fluoroquinolones, a class of potent antibacterial agents, have been studied for their interaction with enzymes like DNA gyrase, a target for these drugs. On the other hand, HGO/HGD, an enzyme involved in tyrosine catabolism, has been extensively analyzed for mutations affecting its function. Interestingly, computational studies have identified specific amino acid substitutions in HGD that can lead to enzyme inactivation, potentially impacting its catalytic activity. While fluoroquinolones primarily target bacterial DNA gyrase, the detailed molecular mechanisms of potential inhibition of HGD by these drugs remain to be fully elucidated. Further research could explore the structural interactions between fluoroquinolones and HGD to determine if there is a direct basis for HGD inhibition by these antibacterial agents.